Work

Real-World Single-Center Experience with Neoadjuvant Gemcitabine, Cisplatin, and Durvalumab in Borderline Resectable Cholangiocarcinoma

Year: 2025

Type: article

Source: Annals of Surgical Oncology

DOI: 10.1245/s10434-025-18046-6

Authors: Yawen Dong, Vanja Podrascanin, Zhihao Li, Jonas Santol, Markus Ammann, Lionel A. Kankeu Fonkoua, Rondell P. Graham, Caitlin B. Conboy, Nguyen H. Tran, Susanne G. Warner, Rory L. Smoot, Patrick P. Starlinger

Institutions: Sigmund Freud Privatuniversität Wien, Mayo Clinic, Universitätsklinikum Wiener Neustadt

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4413115513

FWCI: 10.26

Cites: 25

Cited by: 11

Related to: 10